Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Colonic Neoplasms × Golytely × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Personal Satisfaction 1 Colorectal Neoplasms 1 Colonic Neoplasms 1

Interventions

Leucovorin 35 Fluorouracil 33 Oxaliplatin 31 Bevacizumab 29 Irinotecan 28 Cetuximab 21 Capecitabine 16 Panitumumab 13 IFL protocol 6 Folfox protocol 6 Nivolumab 5 Immunohistochemistry 5 pembrolizumab 4 Ramucirumab 4 Radiotherapy 4 Gene Expression Profiling 4 Floxuridine 4 dehydroftorafur 3 aflibercept 3 Surgical Procedures, Operative 3 Radiosurgery 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Gemcitabine 3 Fluorodeoxyglucose F18 3 Fentanyl 3 Drug Therapy 3 Chemotherapy, Adjuvant 3 Celecoxib 3 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00687830 2017-05-17

CCF

The Cleveland Clinic

Phase 3 Completed

136 enrolled 6 charts

Gastrointestinal

Colonic Neoplasms, Personal Satisfaction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡